Occult  ||| S:0 E:7 ||| JJ
sinusitis  ||| S:7 E:17 ||| NN
may  ||| S:17 E:21 ||| MD
be  ||| S:21 E:24 ||| VB
a  ||| S:24 E:26 ||| DT
key  ||| S:26 E:30 ||| JJ
feature  ||| S:30 E:38 ||| NN
for  ||| S:38 E:42 ||| IN
non-controlled  ||| S:42 E:57 ||| JJ
asthma  ||| S:57 E:64 ||| NN
in  ||| S:64 E:67 ||| IN
children  ||| S:67 E:76 ||| NNS
Sinusitis  ||| S:76 E:86 ||| NNP
is  ||| S:86 E:89 ||| VBZ
frequently  ||| S:89 E:100 ||| RB
associated  ||| S:100 E:111 ||| VBN
with  ||| S:111 E:116 ||| IN
asthma ||| S:116 E:122 ||| NN
.  ||| S:122 E:124 ||| .
The  ||| S:124 E:128 ||| DT
diagnosis  ||| S:128 E:138 ||| NN
and  ||| S:138 E:142 ||| CC
management  ||| S:142 E:153 ||| NN
of  ||| S:153 E:156 ||| IN
patients  ||| S:156 E:165 ||| NNS
with  ||| S:165 E:170 ||| IN
asthma  ||| S:170 E:177 ||| NN
associated  ||| S:177 E:188 ||| VBN
with  ||| S:188 E:193 ||| IN
sinusitis  ||| S:193 E:203 ||| NNS
are  ||| S:203 E:207 ||| VBP
often  ||| S:207 E:213 ||| RB
challenging ||| S:213 E:224 ||| VBG
,  ||| S:224 E:226 ||| ,
though  ||| S:226 E:233 ||| RB
sometimes  ||| S:233 E:243 ||| RB
unsatisfactory ||| S:243 E:257 ||| VBN
.  ||| S:257 E:259 ||| .
Detection  ||| S:259 E:269 ||| NNP
and  ||| S:269 E:273 ||| CC
treatment  ||| S:273 E:283 ||| NN
of  ||| S:283 E:286 ||| IN
sinusitis  ||| S:286 E:296 ||| NN
in  ||| S:296 E:299 ||| IN
asthmatics  ||| S:299 E:310 ||| NNS
may  ||| S:310 E:314 ||| MD
lead  ||| S:314 E:319 ||| VB
to  ||| S:319 E:322 ||| TO
a  ||| S:322 E:324 ||| DT
better  ||| S:324 E:331 ||| JJR
control  ||| S:331 E:339 ||| NN
of  ||| S:339 E:342 ||| IN
asthma  ||| S:342 E:349 ||| JJ
symptoms ||| S:349 E:357 ||| NNS
.  ||| S:357 E:359 ||| .
Most  ||| S:359 E:364 ||| JJS
of  ||| S:364 E:367 ||| IN
the  ||| S:367 E:371 ||| DT
studies  ||| S:371 E:379 ||| NNS
regarding  ||| S:379 E:389 ||| VBG
the  ||| S:389 E:393 ||| DT
relationship  ||| S:393 E:406 ||| NN
between  ||| S:406 E:414 ||| IN
sinusitis  ||| S:414 E:424 ||| NN
and  ||| S:424 E:428 ||| CC
asthma  ||| S:428 E:435 ||| NNS
have  ||| S:435 E:440 ||| VBP
been  ||| S:440 E:445 ||| VBN
conducted  ||| S:445 E:455 ||| VBN
in  ||| S:455 E:458 ||| IN
adults ||| S:458 E:464 ||| NNS
.  ||| S:464 E:466 ||| .
The  ||| S:466 E:470 ||| DT
aim  ||| S:470 E:474 ||| NN
of  ||| S:474 E:477 ||| IN
the  ||| S:477 E:481 ||| DT
present  ||| S:481 E:489 ||| JJ
study  ||| S:489 E:495 ||| NN
was  ||| S:495 E:499 ||| VBD
to  ||| S:499 E:502 ||| TO
evaluate  ||| S:502 E:511 ||| VB
the  ||| S:511 E:515 ||| DT
presence  ||| S:515 E:524 ||| NN
of  ||| S:524 E:527 ||| IN
sinusal  ||| S:527 E:535 ||| JJ
comorbidity  ||| S:535 E:547 ||| NN
in  ||| S:547 E:550 ||| IN
children  ||| S:550 E:559 ||| NNS
with  ||| S:559 E:564 ||| IN
un-controlled  ||| S:564 E:578 ||| JJ
asthma  ||| S:578 E:585 ||| NN
both  ||| S:585 E:590 ||| DT
clinically  ||| S:590 E:601 ||| NN
and  ||| S:601 E:605 ||| CC
through  ||| S:605 E:613 ||| IN
nasal  ||| S:613 E:619 ||| JJ
endoscopy  ||| S:619 E:629 ||| NN
after  ||| S:629 E:635 ||| IN
the  ||| S:635 E:639 ||| DT
first  ||| S:639 E:645 ||| JJ
6  ||| S:645 E:647 ||| CD
months  ||| S:647 E:654 ||| NNS
of  ||| S:654 E:657 ||| IN
treatment ||| S:657 E:666 ||| NN
.  ||| S:666 E:668 ||| .
The  ||| S:668 E:672 ||| DT
present  ||| S:672 E:680 ||| JJ
study  ||| S:680 E:686 ||| NN
included  ||| S:686 E:695 ||| VBD
294  ||| S:695 E:699 ||| CD
consecutive  ||| S:699 E:711 ||| JJ
asthmatic  ||| S:711 E:721 ||| JJ
children  ||| S:721 E:730 ||| NNS
( ||| S:730 E:731 ||| -LRB-
97  ||| S:731 E:734 ||| CD
males ||| S:734 E:739 ||| NNS
,  ||| S:739 E:741 ||| ,
mean  ||| S:741 E:746 ||| JJ
age  ||| S:746 E:750 ||| NN
7.3  ||| S:750 E:754 ||| CD
years ||| S:754 E:759 ||| NNS
) ||| S:759 E:760 ||| -RRB-
.  ||| S:760 E:762 ||| .
Asthma  ||| S:762 E:769 ||| JJ
diagnosis ||| S:769 E:778 ||| NN
,  ||| S:778 E:780 ||| ,
severity  ||| S:780 E:789 ||| JJ
assessment  ||| S:789 E:800 ||| NN
and  ||| S:800 E:804 ||| CC
treatment  ||| S:804 E:814 ||| NN
were  ||| S:814 E:819 ||| VBD
performed  ||| S:819 E:829 ||| VBN
according  ||| S:829 E:839 ||| VBG
to  ||| S:839 E:842 ||| TO
GINA  ||| S:842 E:847 ||| NNP
guidelines ||| S:847 E:857 ||| NNS
.  ||| S:857 E:859 ||| .
Twenty-one  ||| S:859 E:870 ||| CD
patients  ||| S:870 E:879 ||| NNS
with  ||| S:879 E:884 ||| IN
non-controlled  ||| S:884 E:899 ||| JJ
asthma  ||| S:899 E:906 ||| NN
presented  ||| S:906 E:916 ||| VBN
with  ||| S:916 E:921 ||| IN
endoscopic  ||| S:921 E:932 ||| JJ
features  ||| S:932 E:941 ||| NNS
of  ||| S:941 E:944 ||| IN
sinusitis ||| S:944 E:953 ||| NN
,  ||| S:953 E:955 ||| ,
but  ||| S:955 E:959 ||| CC
without  ||| S:959 E:967 ||| IN
any  ||| S:967 E:971 ||| DT
clinical  ||| S:971 E:980 ||| JJ
sign  ||| S:980 E:985 ||| NN
or  ||| S:985 E:988 ||| CC
symptom ||| S:988 E:995 ||| NN
.  ||| S:995 E:997 ||| .
We  ||| S:997 E:1000 ||| PRP
defined  ||| S:1000 E:1008 ||| VBD
such  ||| S:1008 E:1013 ||| JJ
condition  ||| S:1013 E:1023 ||| NN
occult  ||| S:1023 E:1030 ||| NN
sinusitis ||| S:1030 E:1039 ||| NN
.  ||| S:1039 E:1041 ||| .
Not  ||| S:1041 E:1045 ||| RB
only  ||| S:1045 E:1050 ||| RB
overt  ||| S:1050 E:1056 ||| JJ
sinusitis ||| S:1056 E:1065 ||| NN
,  ||| S:1065 E:1067 ||| ,
but  ||| S:1067 E:1071 ||| CC
also  ||| S:1071 E:1076 ||| RB
occult  ||| S:1076 E:1083 ||| JJ
sinusitis  ||| S:1083 E:1093 ||| NN
could  ||| S:1093 E:1099 ||| MD
be  ||| S:1099 E:1102 ||| VB
a  ||| S:1102 E:1104 ||| DT
significant  ||| S:1104 E:1116 ||| JJ
comorbidity  ||| S:1116 E:1128 ||| NN
in  ||| S:1128 E:1131 ||| IN
asthmatic  ||| S:1131 E:1141 ||| JJ
patients ||| S:1141 E:1149 ||| NNS
.  ||| S:1149 E:1151 ||| .
For  ||| S:1151 E:1155 ||| IN
this  ||| S:1155 E:1160 ||| DT
reason ||| S:1160 E:1166 ||| NN
,  ||| S:1166 E:1168 ||| ,
it  ||| S:1168 E:1171 ||| PRP
may  ||| S:1171 E:1175 ||| MD
be  ||| S:1175 E:1178 ||| VB
beneficial  ||| S:1178 E:1189 ||| JJ
to  ||| S:1189 E:1192 ||| TO
determine  ||| S:1192 E:1202 ||| VB
the  ||| S:1202 E:1206 ||| DT
presence  ||| S:1206 E:1215 ||| NN
of  ||| S:1215 E:1218 ||| IN
sinus  ||| S:1218 E:1224 ||| JJ
inflammation  ||| S:1224 E:1237 ||| NN
in  ||| S:1237 E:1240 ||| IN
children  ||| S:1240 E:1249 ||| NNS
with  ||| S:1249 E:1254 ||| IN
non-controlled  ||| S:1254 E:1269 ||| JJ
asthma ||| S:1269 E:1275 ||| NN
,  ||| S:1275 E:1277 ||| ,
even  ||| S:1277 E:1282 ||| RB
when  ||| S:1282 E:1287 ||| WRB
they  ||| S:1287 E:1292 ||| PRP
do  ||| S:1292 E:1295 ||| VBP
not  ||| S:1295 E:1299 ||| RB
present  ||| S:1299 E:1307 ||| JJ
clinical  ||| S:1307 E:1316 ||| JJ
signs  ||| S:1316 E:1322 ||| NNS
or  ||| S:1322 E:1325 ||| CC
symptoms  ||| S:1325 E:1334 ||| NNS
of  ||| S:1334 E:1337 ||| IN
upper  ||| S:1337 E:1343 ||| JJ
airways  ||| S:1343 E:1351 ||| JJ
involvement ||| S:1351 E:1362 ||| NN
.  ||| S:1362 E:1364 ||| .
